BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23875016)

  • 61. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
    Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
    Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
    Roodi N; Bailey LR; Kao WY; Verrier CS; Yee CJ; Dupont WD; Parl FF
    J Natl Cancer Inst; 1995 Mar; 87(6):446-51. PubMed ID: 7861463
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells.
    Lanceta L; O'Neill C; Lypova N; Li X; Rouchka E; Waigel S; Gomez-Gutierrez JG; Chesney J; Imbert-Fernandez Y
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344635
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer.
    Gao S; Ge A; Xu S; You Z; Ning S; Zhao Y; Pang D
    J Exp Clin Cancer Res; 2017 Dec; 36(1):179. PubMed ID: 29216929
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
    Stricker TP; Brown CD; Bandlamudi C; McNerney M; Kittler R; Montoya V; Peterson A; Grossman R; White KP
    PLoS Genet; 2017 Mar; 13(3):e1006589. PubMed ID: 28263985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.
    Thiruchelvam PT; Lai CF; Hua H; Thomas RS; Hurtado A; Hudson W; Bayly AR; Kyle FJ; Periyasamy M; Photiou A; Spivey AC; Ortlund EA; Whitby RJ; Carroll JS; Coombes RC; Buluwela L; Ali S
    Breast Cancer Res Treat; 2011 Jun; 127(2):385-96. PubMed ID: 20607599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.
    Gonzalez-Angulo AM; Iwamoto T; Liu S; Chen H; Do KA; Hortobagyi GN; Mills GB; Meric-Bernstam F; Symmans WF; Pusztai L
    Clin Cancer Res; 2012 Feb; 18(4):1109-19. PubMed ID: 22235097
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
    Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
    Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.
    Jia Y; Song Y; Dong G; Hao C; Zhao W; Li S; Tong Z
    Sci Rep; 2019 Sep; 9(1):12939. PubMed ID: 31506496
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
    Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
    Liu R; Guo CX; Zhou HH
    Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
    Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G
    J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293
    [TBL] [Abstract][Full Text] [Related]  

  • 76. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
    Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
    Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
    Zhang Y; Delahanty R; Guo X; Zheng W; Long J
    Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.
    Tufail R; Jorda M; Zhao W; Reis I; Nawaz Z
    Breast Cancer Res Treat; 2012 Feb; 131(3):743-50. PubMed ID: 21399893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
    Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.